Tag: FDA

FDA: Getinge recalls Maquet/Getinge Cardiosave Intra-Aortic Balloon Pump

Editor's Note The Food and Drug Administration (FDA) on September 30 posted an announcement by Getinge that it is voluntarily initiating a worldwide recall involving a field correction of some 5,223 Maquet/Getinge Cardiosave Intra-Aortic Balloon Pumps (IABP) sold by Datascope Corp. The recall is because of the potential for interruption…

Read More

By: Judy Mathias
September 25, 2018
Share

FDA takes steps to address cybersecurity concerns of medical devices

Editor's Note The Food and Drug Administration (FDA) has taken steps to ensure that medical device manufacturers do as much as possible to defend against hacking and other threats to their devices, according to a new report from the Department of Health & Human Services Office of Inspector General. The…

Read More

By: Judy Mathias
September 12, 2018
Share

FDA: Pharm D Solutions recalls all sterile compounded drugs

Editor's Note The Food and Drug Administration (FDA) on September 10 posted the announcement by Pharm D Solutions, LLC, (Houston, Texas) that it had voluntarily issued a recall of all sterile compounded drugs because of a potential lack of sterility. The company says concerns about practices at the pharmacy that…

Read More

By: Judy Mathias
September 11, 2018
Share

FDA proposes not including three bulk drug substances that outsourcing facilities may use in compounding

Editor's Note The Food and Drug Administration (FDA) on August 28 issued a notice proposing not to include three bulk FDA-approved drug substances−bumetanide, nicardipine hydrochloride, and vasopressin−on the list that outsourcing facilities may use in compounding drug products. The FDA is seeking public comment before finalizing their decision. Comments must…

Read More

By: Judy Mathias
August 29, 2018
Share

FDA issues Safety Alert for Temporary Total Artificial Heart Companion 2 Driver System by SynCardia Systems

Editor's Note The Food & Drug Administration (FDA) on August 17 issued a Safety Alert for SynCardia Systems’ (Tucson, Arizona) Temporary Total Artificial Heart Companion 2 Driver System. Final results from a post-approval study indicate higher mortality and stroke rates for patients initially supported with the C2 Driver System compared…

Read More

By: Judy Mathias
August 20, 2018
Share

Galien Foundation chooses 10 most innovative medical devices of 2018

Editor's Note Nominees for the Best Medical Technology of 2018 were recently chosen by The Galien Foundation, the August 6 Medical Design & Outsourcing reports. Among the 10 most innovative medical devices are: Boston Scientific’s Axios stent and electrocautery enhanced delivery system Boston Scientific’s SpyGlass direct visualization system for cholangiopancreatoscopy…

Read More

By: Judy Mathias
August 15, 2018
Share

FDA: Class I recall of Arkon Anesthesia Delivery System

Editor's Note The Food & Drug Administration on August 10 identified the recall of Spacelabs Healthcare’s (Snoqualmie, Washington) Arkon Anesthesia Delivery System as Class I, the most serious. The recall was issued because of the system going into a “failed state,” during which the mechanical ventilation function stops working. This…

Read More

By: Judy Mathias
August 13, 2018
Share

FDA issues warning on azithromycin

Editor's Note The Food and Drug Administration (FDA) on August 3 issued a warning for azithromycin, saying the antibiotic should not be given long-term to prevent an inflammatory lung condition in patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant. A clinical trial…

Read More

By: Judy Mathias
August 3, 2018
Share

FDA issues update on wearable cardioverter defibrillator

Editor's Note The Food and Drug Administration (FDA) on July 25 issued an update for the Zoll LifeVest 4000 wearable cardioverter defibrillator. The update provides information on efforts by Zoll to remedy the potential hazard of the device failing to deliver a life-saving shock if not replaced soon after displaying…

Read More

By: Judy Mathias
July 31, 2018
Share

FDA finalizes guidance for use of EHR data in clinical studies

Editor's Note The Food and Drug Administration (FDA) on July 19 finalized its guidance for using electronic health record (EHR) data in FDA-regulated clinical studies. The guidance is meant to encourage the use of EHR data in clinical studies and promote greater interoperability between EHR and electronic data capture systems.…

Read More

By: Judy Mathias
July 19, 2018
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat